These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38066833)

  • 1. Exploring Huntington's Disease Diagnosis via Artificial Intelligence Models: A Comprehensive Review.
    Ganesh S; Chithambaram T; Krishnan NR; Vincent DR; Kaliappan J; Srinivasan K
    Diagnostics (Basel); 2023 Dec; 13(23):. PubMed ID: 38066833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling progression subtypes in people with Huntington's disease.
    Raschka T; Li Z; Gaßner H; Kohl Z; Jukic J; Marxreiter F; Fröhlich H
    EPMA J; 2024 Jun; 15(2):275-287. PubMed ID: 38841617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Role of Artificial Intelligence in Mental Healthcare: Current Trends and Future Directions - A Narrative Review for a Comprehensive Insight.
    Alhuwaydi AM
    Risk Manag Healthc Policy; 2024; 17():1339-1348. PubMed ID: 38799612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging pharmacological approaches for Huntington's disease.
    Singh K; Jain D; Sethi P; Gupta JK; Tripathi AK; Kumar S; Sarker SD; Nahar L; Guru A
    Eur J Pharmacol; 2024 Oct; 980():176873. PubMed ID: 39117264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging research trends in artificial intelligence for cancer diagnostic systems: A comprehensive review.
    Abbas S; Asif M; Rehman A; Alharbi M; Khan MA; Elmitwally N
    Heliyon; 2024 Sep; 10(17):e36743. PubMed ID: 39263113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Artificial Intelligence to Diagnosis of Neurodegenerative Diseases.
    Feng T
    Stud Health Technol Inform; 2023 Nov; 308():648-655. PubMed ID: 38007795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence in the diagnosis of glaucoma and neurodegenerative diseases.
    Hasan MM; Phu J; Sowmya A; Meijering E; Kalloniatis M
    Clin Exp Optom; 2024 Mar; 107(2):130-146. PubMed ID: 37674264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scoping review of methodologies for applying artificial intelligence to physical activity interventions.
    An R; Shen J; Wang J; Yang Y
    J Sport Health Sci; 2024 May; 13(3):428-441. PubMed ID: 37777066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Machine-Learning Derived Huntington's Disease Progression Model: Insights for Clinical Trial Design.
    Mohan A; Sun Z; Ghosh S; Li Y; Sathe S; Hu J; Sampaio C
    Mov Disord; 2022 Mar; 37(3):553-562. PubMed ID: 34870344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase inhibitors in cognitive impairment in Huntington's disease: A brief review.
    Vattakatuchery JJ; Kurien R
    World J Psychiatry; 2013 Sep; 3(3):62-4. PubMed ID: 24255877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
    Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
    Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.
    Ellis N; Tee A; McAllister B; Massey T; McLauchlan D; Stone T; Correia K; Loupe J; Kim KH; Barker D; Hong EP; Chao MJ; Long JD; Lucente D; Vonsattel JPG; Pinto RM; Elneel KA; Ramos EM; Mysore JS; Gillis T; Wheeler VC; Medway C; Hall L; Kwak S; Sampaio C; Ciosi M; Maxwell A; Chatzi A; Monckton DG; Orth M; Landwehrmeyer GB; Paulsen JS; Shoulson I; Myers RH; van Duijn E; Rickards H; MacDonald ME; Lee JM; Gusella JF; Jones L; Holmans P
    Biol Psychiatry; 2020 May; 87(9):857-865. PubMed ID: 32087949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diagnosing provider type on longitudinal care for patients with newly diagnosed Huntington's Disease.
    Kim H; Serbin M; Hansen R; Lee K; Haubenberger D; Klepitskaya O; Hinton SC; Jen E
    J Med Econ; 2024 Oct; ():1-13. PubMed ID: 39373538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis.
    Peball M; Heim B; Ellmerer P; Frank F; Busin N; Galffy M; Djamshidian A; Seppi K
    Mov Disord Clin Pract; 2022 Jul; 9(5):628-636. PubMed ID: 35844271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
    Patel AM; Chang E; Paydar C; Reddy SR
    J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence, the Digital Surgeon: Unravelling Its Emerging Footprint in Healthcare - The Narrative Review.
    Shang Z; Chauhan V; Devi K; Patil S
    J Multidiscip Healthc; 2024; 17():4011-4022. PubMed ID: 39165254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnosis and management in early Huntington's disease: a review.
    Schiefer J; Werner CJ; Reetz K
    Degener Neurol Neuromuscul Dis; 2015; 5():37-50. PubMed ID: 32669911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence in The Management of Neurodegenerative Disorders.
    Dhankhar S; Mujwar S; Garg N; Chauhan S; Saini M; Sharma P; Kumar S; Kumar Sharma S; Kamal MA; Rani N
    CNS Neurol Disord Drug Targets; 2024; 23(8):931-940. PubMed ID: 37861051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.